Citadel Advisors
GNPX icon

Citadel Advisors’s Genprex GNPX Stock Holding History

Citadel Advisors’s Portfolio GNPX Stock Details GNPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4
Closed -$44K – 14891
2023
Q4 		$44K Buy
+4
New +$46.1K ﹤0.01% 11915
2023
Q3 		– Hold
0
– – – 13501
2023
Q2 		– Hold
0
– – – 14667
2023
Q1 		– Sell
-1
Closed -$56.4K – 13438
2022
Q4 		$51.7K Buy
+1
New +$56.5K ﹤0.01% 12093
2022
Q3 		– Hold
0
– – – 12057
2022
Q2 		– Sell
-1
Closed -$70.4K – 13318
2022
Q1 		$81K Buy
+1
New +$97.5K ﹤0.01% 12471
2021
Q4 		– Sell
-1
Closed -$83.4K – 13555
2021
Q3 		$67K Buy
+1
New +$129K ﹤0.01% 13184
2020
Q4 		– Sell
-1
Closed -$155K – 11141
2020
Q3 		$76K Hold
1
– – ﹤0.01% 9421
2020
Q2 		$71K Hold
1
– – ﹤0.01% 9155
2020
Q1 		$59K Buy
+1
New +$103K ﹤0.01% 8952
2019
Q3 		– Sell
-1
Closed -$39K – 9381
2019
Q2 		$39K Buy
+1
New +$71.8K ﹤0.01% 8808

Other funds holding GNPX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
NRG
Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return

Citadel Advisors's GNPX Position: Q1 2024 in Review

Citadel Advisors sold out of Genprex (GNPX) in Q1 2024, closing a stake of 4 shares — an estimated $44K sold.

Citadel Advisors first reported a position in GNPX in Q2 2019 and held it in 8 quarters. The position peaked at $81K in Q1 2022. 8 funds tracked by Wall St. Rank hold GNPX as of Q1 2024.

  • Citadel Advisors reported no remaining Genprex position as of Q1 2024 after selling out during the quarter.
  • Citadel Advisors sold 4 Genprex shares in Q1 2024, an estimated $44K.
  • Citadel Advisors first reported a position in Genprex in Q2 2019 and held it in 8 quarters.
  • Citadel Advisors's Genprex position peaked at $81K in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Genprex as of Q1 2024.

Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.